The Swiss Startup Group AG (SSUG) is re-branding its investment arm into Serpentine Ventures (SERV). The company currently hosts 4 funds and has invested into 25 startups in the fields of Information and Communications Technology (ICT), high tech as well as healthtech companies on a selective basis.
The Swiss Startup Group AG (SSUG) is re-branding its investment arm into Serpentine Ventures (SERV). The company currently hosts 4 funds and has invested into 25 startups in the fields of Information and Communications Technology (ICT), high tech as well as healthtech companies on a selective basis.
Through the unique combination of the investment experience, the highly diversified skill set of the team involved, and the access to the SSUG venture platform SERV is at the sweet spot to scout and invest in promising opportunities and to deliver attractive risk-adjusted returns to its investors. The value proposition of SERV has been proven by two exits recently: an Initial Public Offering (IPO) on Euronext and a US trade sale. The investment product suite (multi fund program I) currently offers various fund structures domiciled in Luxembourg covering the entire lifecycle in venture capital:
- Serpentine Rookie Fund I invests mainly in Switzerland in pre-seed companies to capture the highly innovative yet underpenetrated early-stage venture investment market.
- Serpentine Flagship Fund I focuses on technology driven start-ups that are in a seed phase or bridge phase to a Series A investment round with a clear focus on the ICT area.
- Serpentine Growth Fund I (to be launched in 2022) will complete the offering from a lifecycle perspective, supporting startups in their growth phase to enable scaling of their businesses.
- Swiss Diabetes Venture Fund I will harvest risk-adjusted returns by investing in promising early-stage start-ups using novel technologies exclusively addressing the diabetes disease. These diabetes medical technology start-ups can work on hardware, software or any technology linked to detecting, sensing, treating, or curing diabetes mellitus.
Max Meister, Co-Founder of Swiss Startup Group and General Partner of SERV comments: “It was important for us to choose a brand that is representative of the venture business on the one hand and of our Swiss origin on the other. Serpentine is the word for the winding roads found all across the Swiss Alps. Following the Serpentine path makes otherwise unreachable mountain peaks accessible. With our platform we do exactly that, we support start-ups in taking the right decisions on their path to success.”
Mike Baur, Co-Founder & CEO of Swiss Startup Group adds: “The re-branding of our investment arm marks an important milestone in our SSUG growth strategy. With our Serpentine Ventures multi fund program I, we launched our venture asset management offering and give private and institutional investors direct access to the asset class ‘venture’.”
ABOUT SSUG
Founded early 2015 by venture entrepreneurs Mike Baur, Max Meister and Oliver Walzer, the Swiss Startup Group is today the largest privately financed venture platform, and more importantly one of the most active venture investors in Switzerland. The Group offers its investors full and advanced venture asset management delivering attractive risk-adjusted returns. Through its investment arm, Serpentine Ventures, it hosts a diversified range of venture capital and thematic funds and provides its portfolio startups and their founders with a unique ecosystem and a wide range of services throughout their lifecycle, supporting their growth. The Swiss Startup Group has offices in Zurich, Bern and Lausanne.
